Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine association

PURPOSE: To assessment of the aspartate aminotransferase (AST), creatine kinase (CK) and creatine kinase isoenzyme fraction MB (CK-MB) serum activity in female dogs anesthetized with ketamine S (+), atropine and xylazine in several associations. METHODS: Twenty three healthy female dogs randomly distributed in four groups named as GI (n=6), GII (n=6), GIII (n=6) and GIV (n=5) were treated respectively with atropine and ketamine S(+) (0.04mg/kg; 10 mg/kg); ketamine S(+) (10 mg/kg); atropine, xylazine and ketamine S(+) (0.04mg/kg; 1.1 mg/kg; 10 mg/kg) and xylazine and ketamine S(+) (1.1 mg/kg; 10 mg/kg). AST, CK and CK-MB serum activity measurement before pre-medication (M0) and one, two, three, six, 12, 24, 36 hours after. RESULTS: There was no significant change in AST, CK e CK-MB serum activity among groups. However, CK serum activity in relation to moments within the groups was increased in all groups over the time in spite of treatment, except GI. In relation to CK-MB activity, in the moments within the group, it was observed an increase compared to baseline in all groups. CONCLUSION: Creatine kinase and creatine kinase fraction MB isoenzyme showed changes in their mean values remained higher than baseline for a longer time in GIII and GIV.

Saved in:
Bibliographic Details
Main Authors: Franco,Leandro Guimarães, Fioravanti,Maria Clorinda Soares, Damasceno,Adilson Donizeti, Borges,Aline Cardoso, Soares,Lorena Karine, Rabelo,Rogério Elias, Silva,Luiz Antônio Franco da
Format: Digital revista
Language:English
Published: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2009
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502009000100008
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-86502009000100008
record_format ojs
spelling oai:scielo:S0102-865020090001000082009-01-14Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine associationFranco,Leandro GuimarãesFioravanti,Maria Clorinda SoaresDamasceno,Adilson DonizetiBorges,Aline CardosoSoares,Lorena KarineRabelo,Rogério EliasSilva,Luiz Antônio Franco da Isoenzymes Atropine Xylazine Heart Ischemia Anesthetics, Dissociative Dogs PURPOSE: To assessment of the aspartate aminotransferase (AST), creatine kinase (CK) and creatine kinase isoenzyme fraction MB (CK-MB) serum activity in female dogs anesthetized with ketamine S (+), atropine and xylazine in several associations. METHODS: Twenty three healthy female dogs randomly distributed in four groups named as GI (n=6), GII (n=6), GIII (n=6) and GIV (n=5) were treated respectively with atropine and ketamine S(+) (0.04mg/kg; 10 mg/kg); ketamine S(+) (10 mg/kg); atropine, xylazine and ketamine S(+) (0.04mg/kg; 1.1 mg/kg; 10 mg/kg) and xylazine and ketamine S(+) (1.1 mg/kg; 10 mg/kg). AST, CK and CK-MB serum activity measurement before pre-medication (M0) and one, two, three, six, 12, 24, 36 hours after. RESULTS: There was no significant change in AST, CK e CK-MB serum activity among groups. However, CK serum activity in relation to moments within the groups was increased in all groups over the time in spite of treatment, except GI. In relation to CK-MB activity, in the moments within the group, it was observed an increase compared to baseline in all groups. CONCLUSION: Creatine kinase and creatine kinase fraction MB isoenzyme showed changes in their mean values remained higher than baseline for a longer time in GIII and GIV.info:eu-repo/semantics/openAccessSociedade Brasileira para o Desenvolvimento da Pesquisa em CirurgiaActa Cirúrgica Brasileira v.24 n.1 20092009-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502009000100008en10.1590/S0102-86502009000100008
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Franco,Leandro Guimarães
Fioravanti,Maria Clorinda Soares
Damasceno,Adilson Donizeti
Borges,Aline Cardoso
Soares,Lorena Karine
Rabelo,Rogério Elias
Silva,Luiz Antônio Franco da
spellingShingle Franco,Leandro Guimarães
Fioravanti,Maria Clorinda Soares
Damasceno,Adilson Donizeti
Borges,Aline Cardoso
Soares,Lorena Karine
Rabelo,Rogério Elias
Silva,Luiz Antônio Franco da
Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine association
author_facet Franco,Leandro Guimarães
Fioravanti,Maria Clorinda Soares
Damasceno,Adilson Donizeti
Borges,Aline Cardoso
Soares,Lorena Karine
Rabelo,Rogério Elias
Silva,Luiz Antônio Franco da
author_sort Franco,Leandro Guimarães
title Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine association
title_short Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine association
title_full Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine association
title_fullStr Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine association
title_full_unstemmed Assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine S(+), atropin and xylazine association
title_sort assessment of serum enzymatic markers of cardiomyocytes injury in female dogs submitted to ketamine s(+), atropin and xylazine association
description PURPOSE: To assessment of the aspartate aminotransferase (AST), creatine kinase (CK) and creatine kinase isoenzyme fraction MB (CK-MB) serum activity in female dogs anesthetized with ketamine S (+), atropine and xylazine in several associations. METHODS: Twenty three healthy female dogs randomly distributed in four groups named as GI (n=6), GII (n=6), GIII (n=6) and GIV (n=5) were treated respectively with atropine and ketamine S(+) (0.04mg/kg; 10 mg/kg); ketamine S(+) (10 mg/kg); atropine, xylazine and ketamine S(+) (0.04mg/kg; 1.1 mg/kg; 10 mg/kg) and xylazine and ketamine S(+) (1.1 mg/kg; 10 mg/kg). AST, CK and CK-MB serum activity measurement before pre-medication (M0) and one, two, three, six, 12, 24, 36 hours after. RESULTS: There was no significant change in AST, CK e CK-MB serum activity among groups. However, CK serum activity in relation to moments within the groups was increased in all groups over the time in spite of treatment, except GI. In relation to CK-MB activity, in the moments within the group, it was observed an increase compared to baseline in all groups. CONCLUSION: Creatine kinase and creatine kinase fraction MB isoenzyme showed changes in their mean values remained higher than baseline for a longer time in GIII and GIV.
publisher Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
publishDate 2009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502009000100008
work_keys_str_mv AT francoleandroguimaraes assessmentofserumenzymaticmarkersofcardiomyocytesinjuryinfemaledogssubmittedtoketaminesatropinandxylazineassociation
AT fioravantimariaclorindasoares assessmentofserumenzymaticmarkersofcardiomyocytesinjuryinfemaledogssubmittedtoketaminesatropinandxylazineassociation
AT damascenoadilsondonizeti assessmentofserumenzymaticmarkersofcardiomyocytesinjuryinfemaledogssubmittedtoketaminesatropinandxylazineassociation
AT borgesalinecardoso assessmentofserumenzymaticmarkersofcardiomyocytesinjuryinfemaledogssubmittedtoketaminesatropinandxylazineassociation
AT soareslorenakarine assessmentofserumenzymaticmarkersofcardiomyocytesinjuryinfemaledogssubmittedtoketaminesatropinandxylazineassociation
AT rabelorogerioelias assessmentofserumenzymaticmarkersofcardiomyocytesinjuryinfemaledogssubmittedtoketaminesatropinandxylazineassociation
AT silvaluizantoniofrancoda assessmentofserumenzymaticmarkersofcardiomyocytesinjuryinfemaledogssubmittedtoketaminesatropinandxylazineassociation
_version_ 1756400854542319616